HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marek Cegła Selected Research

4- (3- (4- (2- methoxyphenyl)piperazine- 1- yl)propoxy)- 9H- xanthen- 9- one

1/2013Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marek Cegła Research Topics

Disease

3Seizures (Absence Seizure)
03/2016 - 05/2008
2Cardiac Arrhythmias (Arrythmia)
01/2013 - 05/2008
1Malaria
12/2021
1Communicable Diseases (Infectious Diseases)
12/2021
1Premature Cardiac Complexes (Extrasystoles)
05/2008

Drug/Important Bio-Agent (IBA)

3Pentylenetetrazole (Metrazol)IBA
03/2016 - 05/2008
1Pharmaceutical PreparationsIBA
12/2021
14- (3- (4- (2- methoxyphenyl)piperazine- 1- yl)propoxy)- 9H- xanthen- 9- oneIBA
01/2013
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2013
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2013
1XanthonesIBA
01/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
05/2008
1CalciumIBA
05/2008

Therapy/Procedure

1Intravenous Injections
01/2013